The epidermal growth factor receptor (EGFR) is a potent tyrosine kinase, which regulates basic cell functions such as proliferation.  EGFR has been strongly associated with poor prognosis in many types of cancer, prompting the design of highly specific and potent EGFR inhibitors to control tumour growth and metastasis,  Currently, EGFR-targeted therapies are used as an additional line of anticancer treatments in patients with non–small-cell lung … Continue reading Researchers identify a previously unknown mechanism in cancer metastasis.